LSE - Delayed Quote GBp

Haleon plc (HLN.L)

323.90 +0.90 (+0.28%)
At close: May 28 at 4:35 PM GMT+1
Loading Chart for HLN.L
DELL
  • Previous Close 323.00
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 371.20
  • Volume 215,082
  • Avg. Volume 27,053,143
  • Market Cap (intraday) 29.58B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 26.99
  • EPS (TTM) 0.12
  • Earnings Date Aug 1, 2024 - Aug 15, 2024
  • Forward Dividend & Yield 0.06 (1.86%)
  • Ex-Dividend Date Mar 14, 2024
  • 1y Target Est 366.00

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

www.haleon.com

25,408

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HLN.L

Performance Overview: HLN.L

Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HLN.L
1.99%
FTSE 100
6.74%

1-Year Return

HLN.L
0.03%
FTSE 100
8.22%

3-Year Return

HLN.L
1.85%
FTSE 100
14.27%

5-Year Return

HLN.L
1.85%
FTSE 100
14.27%

Compare To: HLN.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HLN.L

Valuation Measures

Annual
As of 5/24/2024
  • Market Cap

    29.58B

  • Enterprise Value

    38.04B

  • Trailing P/E

    27.61

  • Forward P/E

    17.95

  • PEG Ratio (5yr expected)

    1.65

  • Price/Sales (ttm)

    2.66

  • Price/Book (mrq)

    1.78

  • Enterprise Value/Revenue

    3.38

  • Enterprise Value/EBITDA

    18.14

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.64%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    11.24B

  • Net Income Avi to Common (ttm)

    1.08B

  • Diluted EPS (ttm)

    0.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.04B

  • Total Debt/Equity (mrq)

    57.42%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: HLN.L

Company Insights: HLN.L

Research Reports: HLN.L

People Also Watch